A panel of 4 circulating microRNAs (126-5p, 150-5p, 452-5p, and 543) discriminates dogs with splenic hemangiosarcoma from those with noncancerous splenic masses
American Journal of Veterinary Research · 2026
DOI: 10.2460/ajvr.25.07.0258 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Veterinary Research, 2026. Verfasst von Janet A Grimes und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, University of Georgia, Athens, GA. Hauptthemen laut MEDLINE: Hemangiosarcoma, Dog Diseases, Splenic Neoplasms, MicroRNAs. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To identify a panel of circulating microRNAs (miRNAs) that accurately discriminates dogs with splenic hemangiosarcoma from those with noncancerous splenic masses.
Methods
Serum samples from 10 dogs with hemangiosarcoma and 20 dogs with noncancerous splenic masses were included. Quantitative reverse transcription PCR was performed for 8 candidate miRNAs (miRNA [miR]-126-5p, miR-150-5p, miR-203a-3p, miR-214-3p, miR-452-5p, miR-494-3p, miR-497-5p, and miR-543) and 2 reference genes (miR-16-5p and miR-93-5p). Multivariable logistic regression was performed to identify a panel of miRNAs diagnostic for hemangiosarcoma.
Results
The combination of miR-126-5p, miR-150-5p, miR-452-5p, and miR-543 had an area under the curve of 0.930, a sensitivity of 80%, a specificity of 90%, and a Youden J of 0.700 for discriminating dogs with hemangiosarcoma from those with noncancerous splenic masses.
Conclusions
This panel of 4 miRNAs can be used to discriminate noncancerous splenic masses from hemangiosarcoma in dogs with splenic masses. Clinical Relevance The ability to determine the nature of a splenic mass prior to surgery will provide veterinarians and their clients with important knowledge prior to surgery. If a mass is not hemangiosarcoma, owners may be more likely to proceed with surgery rather than euthanasia. Knowing that a mass is hemangiosarcoma will provide information to owners on the need for adjuvant therapy following surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, University of Georgia, Athens, GA.
- Department of Population Health, College of Veterinary Medicine, University of Georgia, Athens, GA.
ORCID-Profile: Janet A Grimes
Zitieren
APA
Grimes, J. A., & Schmiedt, J. M. (2026). A panel of 4 circulating microRNAs (126-5p, 150-5p, 452-5p, and 543) discriminates dogs with splenic hemangiosarcoma from those with noncancerous splenic masses. American Journal of Veterinary Research. https://doi.org/10.2460/ajvr.25.07.0258
Vancouver
Grimes JA, Schmiedt JM. A panel of 4 circulating microRNAs (126-5p, 150-5p, 452-5p, and 543) discriminates dogs with splenic hemangiosarcoma from those with noncancerous splenic masses. American Journal of Veterinary Research. 2026. doi:10.2460/ajvr.25.07.0258
BibTeX
@article{Grimes2026,
author = {Grimes, Janet A and Schmiedt, Jennifer M},
title = {A panel of 4 circulating microRNAs (126-5p, 150-5p, 452-5p, and 543) discriminates dogs with splenic hemangiosarcoma from those with noncancerous splenic masses},
journal = {American Journal of Veterinary Research},
year = {2026},
doi = {10.2460/ajvr.25.07.0258}
}
EUVIMED